Picture of Acousort AB logo

ACOU — Acousort AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: AcouSort's Role In Blue4Therapy Project Expands

Oct 14 (Reuters) - Acousort AB  ACOUS.ST :
    * ACOUSORT'S ROLE IN THE BLUE4THERAPY PROJECT EXPANDS - SEK
700,000 IN ADDITIONAL REVENUE IN 2022
    * BLUECELL HAS NOW COMMISSIONED ACOUSORT TO CARRY OUT WORK,
WHICH
WILL GENERATE REVENUES OF SEK 700,000 IN 2022

Source text for Eikon:  ID:nWkr6zSQQC 
Further company coverage:  ACOUS.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Acousort AB

See all news